DOLO MARATON

Información principal

  • Denominación comercial:
  • DOLO MARATON
  • formulario farmacéutico:
  • Gel
  • Usar para:
  • Humanos
  • Tipo de medicina:
  • medicamento alopático

Documentos

  • para el público en general:
  • El prospecto de información de este producto no está disponible actualmente, puede enviar una petición a nuestro servicio al cliente y le notificaremos tan pronto como nos sea posible para conseguirlo.


    Solicitar el prospecto de información al público.

Localización

  • Disponible en:
  • DOLO  MARATON
    Cuba
  • Idioma:
  • español

Otros datos

Estado

  • Fuente:
  • CECMED - Autoridad Reguladora de Medicamentos, Equipos y Dispositivos Médicos - Cuba
  • Número de autorización:
  • 049-17d3
  • última actualización:
  • 10-05-2018

Ficha Técnica

RESUMEN DE LAS CARACTERÍSTICAS DEL PRODUCTO

Nombre del producto:

DOLO® MARATON

Forma farmacéutica:

Fortaleza:

-

Presentación:

Frasco de PEAD con 60 g.

Titular del Registro Sanitario, país:

ESTABLECIMIENTOS ANCALMO S.A

DE C.V., ANTIGUO CUSCATLÁN, EL SALVADOR.

Fabricante, país:

LABORATORIOS ANCALMO, ANTIGUO

CUSCATLÁN,

EL SALVADOR.

Número de Registro Sanitario:

049-17D3

Fecha de Inscripción:

6 de julio de

2017.

Composición:

Cada 100 g contiene:

Alcanfor

Eucaliptol

Clorhidrato de lidocaína

Mentol cristalizado

Salicilato de metilo

7,000 g

3,000 g

0,500 g

7,000 g

7,000 g

Etanol

7,5 mL

Plazo de validez:

36 meses

Condiciones de almacenamiento:

Almacenar por debajo de 30° C.

Indicaciones terapéuticas:

Frotar el área afectada para aliviar el dolor muscular causado por estrés, golpes, torceduras,

tortícolis y reumatismo.

Contraindicaciones:

No se aplique a personas alérgicas a los componentes de la fórmula ni pacientes alérgicos al

acido acetil salicílico.

No debe aplicarse en heridas abiertas, ojos, boca y genitales.

Precauciones:

Ver Advertencias.

Advertencias especiales y precauciones de uso:

No se aplique por tiempo prolongado ni en áreas extensas.

En caso de irritación excesiva de la piel, suspéndase de inmediato la aplicación de este gel y

consulte a su médico.

Efectos indeseables:

Puede presentarse irritación de la piel, eritema y rara vez urticaria mínima.

Posología y método de administración:

Aplíquese en el área afectada frotando ligeramente varias veces al día.

Interacción con otros productos medicinales y otras formas de interacción:

Ninguna conocida por vía cutánea.

Uso en Embarazo y lactancia:

No procede.

Efectos sobre la conducción de vehículos/maquinarias:

No procede.

Sobredosis:

No se han reportado casos de sobre-dosificación.

En caso de ingesta se debe inducir vomito o en su caso lavado gástrico.

El contacto accidental con los ojos puede producir irritación.

Propiedades farmacodinámicas:

No se ha reportado hasta la fecha.

Propiedades farmacocinéticas (Absorción, distribución, biotransformación, eliminación):

No se ha reportado hasta la fecha.

Instrucciones de uso, manipulación y destrucción del remanente no utilizable del producto:

No procede.

Fecha de aprobación/ revisión del texto: 6 de julio de 2017.

  • El prospecto de información de este producto no está disponible actualmente, puede enviar una petición a nuestro servicio al cliente y le notificaremos tan pronto como nos sea posible para conseguirlo.

    Solicitar el prospecto de información al público.



  • Los documentos en otros idiomas están disponibles aquí

15-11-2018

informe de OMS sobre consumo de antibióticos 2016-2018.

OMS, 12 de noviembre de 2018 Saber cómo se utilizan los antibiicos es un paso importante para reducir resistencias. El informe también documenta los primeros esfuerzos de la Organización Mundial de la Salud (OMS) y los países participantes para monitorear los antimicrobianos, describe la metodología global de la OMS para la recopilación de datos y destaca los desafíos y los pasos futuros en el monitoreo antimicrobiano.

REDCIMLAC - Red de Centros de Información de Medicamentos de Latinoamérica y el Caribe

15-11-2018

Recommendations on the use of the proportionality approach in the framework of risk assessment for pesticide residues

Recommendations on the use of the proportionality approach in the framework of risk assessment for pesticide residues

Published on: Wed, 14 Nov 2018 The technical report reflects the outcome of the discussions and agreements that were reached in the pesticides peer review meeting on residues and maximum residue levels regarding the principles and guidance for application of the proportionality concept in the risk assessment methodologies used at European level for the estimation of the maximum residue levels for pesticides. In addition, practical experiences on the use of the proportionality approach gained by EFSA hav...

Europe - EFSA - European Food Safety Authority Publications

9-11-2018

Un dispositivo comprueba el correcto drenaje en hidrocefalia

Un dispositivo comprueba el correcto drenaje en hidrocefalia

En la población con hidrocefalia un dolor de cabeza puede derivar en una consulta en urgencias, escáneres, radiación e incluso cirugía. Ahora un sensor cutáneo, creado a imagen de una tirita, y desarrollado por la Universidad de Northwestern, en Estados Unidos, podría cambiar el abordaje de la hidrocefalia al determinar si la desviación del fluido […]

Cuba - infomed - Red de Salud de Cuba

5-11-2018

Describen un nuevo complejo ligamentoso en el tobillo: el fibulotalocalcáneo lateral

Describen un nuevo complejo ligamentoso en el tobillo: el fibulotalocalcáneo lateral

La identificación de unas fibras descartadas habitualmente en las disecciones anatómicas ha permitido a un equipo de la Universidad de Barcelona (UB) describir un nuevo ligamento en la parte lateral del tobillo: el fibulotalocalcáneo lateral. El hallazgo puede tener implicaciones en el abordaje de los esguinces de tobillo en los que persiste el dolor o […]

Cuba - infomed - Red de Salud de Cuba

11-10-2018

Wild boar in focus: Review of existing models on spatial distribution and density of wild boar and proposal for next steps

Wild boar in focus: Review of existing models on spatial distribution and density of wild boar and proposal for next steps

Published on: Wed, 10 Oct 2018 00:00:00 +0200 This report provides a review of existing models for predicting the spatial distribution and abundance of wild boar at various scales (global, continental, national and regional) in order to inform the development of a new model to produce estimates of wild boar abundance at European level. The review identifies and discusses a range of models based on a wide variety of data types, corresponding to those targeted by the data collection model set by ENETwild,...

Europe - EFSA - European Food Safety Authority Publications

20-9-2018

Lumbalgia: sin corticosteroides

Prescrire, 1 de septiembre de 2018 No hay evidencia de que los corticosteroides sistémicos tengan alguna eficacia en el dolor lumbar, más allá de un efecto placebo. Además, exponen a los pacientes a numerosos efectos adversos.

REDCIMLAC - Red de Centros de Información de Medicamentos de Latinoamérica y el Caribe

19-9-2018

National dietary survey in 2012‐2016 on the general population aged 1‐79 years in the Netherlands

National dietary survey in 2012‐2016 on the general population aged 1‐79 years in the Netherlands

Published on: Tue, 18 Sep 2018 00:00:00 +0200 During the years 2012‐2016, the Dutch National Food Consumption survey was conducted in the Netherlands. For the survey, a random sample was drawn from consumer panels stratified by age and gender and maintained representative to the population with regard to region, address density and educational level. Complete results were obtained for 4,313 persons (response rate 65%); including toddlers, children, adolescents, adults and elderly. Pregnant or lactating ...

Europe - EFSA - European Food Safety Authority Publications

14-9-2018

Development of an automated multienzymatic biosensor for risk assessment of pesticide contamination in water and food

Development of an automated multienzymatic biosensor for risk assessment of pesticide contamination in water and food

Published on: Mon, 27 Aug 2018 00:00:00 +0200 The goal of this research is to better address the problems related to the widespread presence of pesticides in the environment. Despite the unquestionable utility of the pesticides against various pests in the agricultural field, most pesticides and the corresponding pesticide residues are toxic to the environment and hazardous to human health. The recent literature on organophosphate compounds emphasises a clear correlation between their use and the occurr...

Europe - EFSA - European Food Safety Authority Publications

12-9-2018

Application of data science in risk assessment and early warning

Application of data science in risk assessment and early warning

Published on: Mon, 27 Aug 2018 00:00:00 +0200 The currently applied approaches, procedures and tools used for the identification of emerging risks vary greatly among Member States of the EU. EFSA established a structured approach for emerging risk identification that mainly consists of systematically searching, collecting, collating and analysing information and data. In addition, EFSA concluded that new methodologies and tools are needed to facilitate efficient and transparent sharing of data, knowledg...

Europe - EFSA - European Food Safety Authority Publications

11-9-2018

Risk assessment of substances used in food supplements: the example of the botanical Gymnema sylvestre

Risk assessment of substances used in food supplements: the example of the botanical Gymnema sylvestre

Published on: Tue, 28 Aug 2018 00:00:00 +0200 Botanicals and preparations derived from these are among the substances frequently added to foods and food supplements, yet the safety of many botanicals has not been systematically assessed. In the context of the EU‐FORA fellowship programme, the fellow performed an assessment on the safety of the botanical Gymnema sylvestre, in accordance with EFSA's guidance on the assessment of safety of botanicals. Although preparations of G. sylvestre are marketed as f...

Europe - EFSA - European Food Safety Authority Publications

11-9-2018

Novel foods: a risk profile for the house cricket (Acheta domesticus)

Novel foods: a risk profile for the house cricket (Acheta domesticus)

Published on: Tue, 28 Aug 2018 00:00:00 +0200 Novel foods could represent a sustainable alternative to traditional farming and conventional foodstuffs. Starting in 2018, Regulation (EU) 2283/2015 entered into force, laying down provisions for the approval of novel foods in Europe, including insects. This Approved Regulation establishes the requirements that enable Food Business Operators to bring new foods into the EU market, while ensuring high levels of food safety for European consumers. The present ...

Europe - EFSA - European Food Safety Authority Publications

11-9-2018

Risk assessment of antimicrobial resistance along the food chain through culture‐independent methodologies

Risk assessment of antimicrobial resistance along the food chain through culture‐independent methodologies

Published on: Mon, 27 Aug 2018 00:00:00 +0200 Antimicrobial resistance (AMR) represents a major challenge for Public Health and the scientific community, and requires immediate and drastic solutions. Acquired resistance to certain antimicrobials is already widespread to such an extent that their efficacy in the treatment of certain life‐threatening infections is already compromised. To date, the emergence and spread of AMR has been attributed to the use, misuse or indiscriminate use of antibiotics as th...

Europe - EFSA - European Food Safety Authority Publications

11-9-2018

Assessment of occupational and dietary exposure to pesticide residues

Assessment of occupational and dietary exposure to pesticide residues

Published on: Mon, 27 Aug 2018 00:00:00 +0200 Plant protection products (PPPs) are pesticides containing at least one active substance that drives specific actions against pests (diseases). PPPs are regulated in the EU and cannot be placed on the market or used without prior authorisation. EFSA assesses the possible risks of the use of active substances to humans and environment. Member States decide whether or not to approve their use at EU level. Furthermore, Member States decide at national level on ...

Europe - EFSA - European Food Safety Authority Publications

29-8-2018

Explanatory note on the determination of newly expressed protein levels in the context of genetically modified plant applications for EU market authorisation

Explanatory note on the determination of newly expressed protein levels in the context of genetically modified plant applications for EU market authorisation

Published on: Mon, 20 Aug 2018 00:00:00 +0200 Genetically modified organisms are subject to a risk assessment and regulatory approval before entering the European market. According to legislation (Directive 2001/18/EC, Regulation (EC) No 1829/2003 and Regulation (EU) No 503/2013) and the EFSA guidance documents on the risk assessment of food and feed from genetically modified (GM) plants and on the environmental risk assessment of GM plants, applicants need to perform a molecular characterisation of any...

Europe - EFSA - European Food Safety Authority Publications

29-8-2018

Strategic partnership with German data providing institutions on data quality (Pilot project) – Final report

Strategic partnership with German data providing institutions on data quality (Pilot project) – Final report

Published on: Tue, 07 Aug 2018 00:00:00 +0200 This report describes the framework of collection, management and transmission of food safety data in the Federal Republic of Germany. To adjust optimally the data governance processes to the requirements defined by the EFSA, measures had been agreed upon in order to improve the specified situation. Subsequent methodological system enhancements related to data quality are given as well as structural adjustments and the development and implementation of suppo...

Europe - EFSA - European Food Safety Authority Publications

10-8-2018

tratamiento tópico con lidocaína en el dolor neuropático. infarma

infarma Vol. 9 Servicio Canario de Salud, agosto 2018 El lugar en la terapéutica de los apósitos de lidocaína no está claro en la actualidad: la evidencia que respalda su uso en la neuralgia postherpética es débil y limitada. Por todo lo cual, así como por la falta de datos comparativos y el coste que suponen, su uso quedaría restringido a pacientes que no toleren las terapias sistémicas de primera línea para la NPH, o cuando éstas hayan sido ineficaces o estén contraindicadas  

REDCIMLAC - Red de Centros de Información de Medicamentos de Latinoamérica y el Caribe

19-6-2018

Various Aortic Endovascular Graft Systems: Letter to Health Care Providers - UPDATE on Type III Endoleaks

Various Aortic Endovascular Graft Systems: Letter to Health Care Providers - UPDATE on Type III Endoleaks

Based on new information, the Endologix AFX with Strata device is at greater risk for a Type III endoleak compared to other endovascular AAA graft systems.

FDA - U.S. Food and Drug Administration

7-6-2018

Ovejoterapia: la nueva metodología que impacta física y cognitivamente en personas con discapacidad

Ovejoterapia: la nueva metodología que impacta física y cognitivamente en personas con discapacidad

“Las ovejas son una especie altamente social, superinteligentes, y son animales muy poco agresivos, por eso considerábamos que cumplían con requisitos mínimos para trabajar con niños en terapia, fue así como se nos ocurrió incluirlas en el trabajo terapéutico”, relata María José Ubilla, veterinaria, etóloga y coordinadora del Centro de Terapia Asistidas con Animales (CTAA) […]

Cuba - infomed - Red de Salud de Cuba

4-6-2018

La ciencia básica impulsa la medicina personalizada del dolor

La ciencia básica impulsa la medicina personalizada del dolor

El dolor es inherente al ser humano, pero también es prevenible y se puede aliviar en muchas ocasiones. Por ello, “Vivir sin dolor”, el lema escogido para el XV Congreso de la Sociedad Española del Dolor (SED) que ha concluido el pasado fin de semana en Palma de Mallorca y en el que han participado […]

Cuba - infomed - Red de Salud de Cuba

30-5-2018

Dolor cero postoperatorio, una realidad gracias al sufentanilo sublingual

Dolor cero postoperatorio, una realidad gracias al sufentanilo sublingual

Las técnicas quirúrgicas desde siempre se han asociado al dolor. Ya sea una hernia o una operación a corazón abierto, una intervención quirúrgica produce un dolor que hasta hace poco era inseparable a la cirugía. “El anestesista proporciona el grado de sedación y analgesia que todos deseamos para no sufrir en vano por los procedimientos […]

Cuba - infomed - Red de Salud de Cuba

11-9-2018

 Risk assessment guideline focus group meeting, European Medicines Agency, London, UK, From: 19-Sep-2018, To: 19-Sep-2018

Risk assessment guideline focus group meeting, European Medicines Agency, London, UK, From: 19-Sep-2018, To: 19-Sep-2018

The Antimicrobials Working Party of the European Medicines Agency’s Committee for Medicinal Products for Veterinary Use (CVMP) is holding a focus group meeting with stakeholders to discuss the revision of the antimicrobial veterinary medicinal product risk assessment guideline, following a public consultation on the draft revised guideline ending on 31 October 2018. The meeting will focus on topics identified during this public consultation. This guideline aims to provide guidance to marketing authorisat...

Europe - EMA - European Medicines Agency

27-7-2018

Scientific guideline:  Reflection paper on dose optimisation of established veterinary antibiotics in the context of summary of product characteristics (SPC) harmonisation, draft: consultation open

Scientific guideline: Reflection paper on dose optimisation of established veterinary antibiotics in the context of summary of product characteristics (SPC) harmonisation, draft: consultation open

Established veterinary antibiotics are not always used at the authorised dose, and the dose may need to be reviewed in order to maintain their effectiveness whilst limiting the risks of antimicrobial resistance. Before a new dose is introduced, the company would typically have to conduct new studies to ensure it does not negatively affect the safety of the target animal, the consumer of animal produce, or the environment. This may reduce product availability, which could have a negative impact on antimic...

Europe - EMA - European Medicines Agency

9-7-2018

Scientific guideline:  Concept paper on the need to develop a reflection paper on development of medicinal products to prevent and treat acute kidney injury, draft: consultation open

Scientific guideline: Concept paper on the need to develop a reflection paper on development of medicinal products to prevent and treat acute kidney injury, draft: consultation open

The concept paper will include discussion of and recommendations for the requirements for evaluation and development of medicinal products for the prevention and/or treatment of acute kidney injury (AKI) and its long-term complications. Relevant topics for discussion include patient populations, endpoints, study methodology, and study duration.

Europe - EMA - European Medicines Agency